Abstract
Activated CD8+ T cells in the tumor and cytotoxic T cell signature correlate with immune response in patients receiving neoadjuvant immunotherapy for treatment of muscle invasive bladder cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have